| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |